Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Research and development | 345M | 102M |
| Selling, general and administrative | 48M | 49M |
| Operating expenses | 393M | 151M |
| Operating income | −393M | −151M |
| Net income | −360M | −110M |
| Earnings per share | −3.19 | −1.01 |
| Earnings per share, diluted | −3.19 | −1.01 |
| Weighted average shares | 113M | 109M |
| Weighted average shares, diluted | 113M | 109M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 118M | 166M | 100M | 34M | 38M | 27M | 50M | 44M |
| Current assets | 608M | 716M | 739M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −279M | −88M |
| Share-based compensation | 41M | 30M |
| Investing cash flow | 341M | −553M |
| Financing cash flow | 76M | 612M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 827M |
| 866M |
| 907M |
| 937M |
| 946M |
| Total assets | 608M | 716M | 739M | 828M | 867M | 908M | 938M | 947M |
| Current liabilities | 106M | 77M | 26M | 32M | 20M | 27M | 26M | 25M |
| Total liabilities | 106M | 77M | 26M | 32M | 20M | 28M | 26M | 26M |
| Equity | 502M | 639M | 713M | 795M | 847M | 880M | 911M | 921M |
| Shares outstanding | 116M | 115M | 112M | 112M | 112M | 112M | 111M | 111M |
| Shares issued | 116M | 115M | 112M | 112M | 112M | 112M | 111M | 111M |
| Treasury shares | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |